REFERENCES
- Amsterdam J. D. A double blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive disorder. Journal of Clinical Psychiatry 2003; 64(2)208–214, [INFOTRIEVE], [CSA]
- Amsterdam J. D., Shults J. MAOI efficacy and safety in advanced stage treatment-resistant depression: A retrospective study. Journal of Affective Disorders 2005; 89(1)183–188, [INFOTRIEVE], [CROSSREF], [CSA]
- Barrett J. S., Hochadel T. J., Morales R. J., Rohatagi S., DeWitt K. E., Watson S. K., et al. Pressor response to tyramine after single 24-hour application of a selegiline transdermal system in healthy males. The Journal of Clinical Pharmacology 1997; 37(3)238–247, [CSA]
- Bodkin J. A., Amsterdam J. D. Transdermal selegiline in major depression: A double-blind, placebo-controlled, parallel-group study in outpatients. American Journal of Psychiatry 2002; 159(11)1869–1875, [INFOTRIEVE], [CROSSREF], [CSA]
- Fagiolini A., Kupner D. J. Is treatment resistant depression a unique subtype of depression?. Biological Psychiatry 2003; 53(8)640–648, [INFOTRIEVE], [CROSSREF], [CSA]
- Fava M. Diagnosis and definition of treatment-resistant depression. Biological Psychiatry 2003; 53(8)649–659, [INFOTRIEVE], [CROSSREF], [CSA]
- Han D., Wang E. C. Remission from depression: A review of venlafaxine: Clinical and economic evidence. Pharmacoeconomics 2005; 23(6)567–581, [INFOTRIEVE], [CROSSREF], [CSA]
- Henkel V., Mergl R., Allgaier A. K., Kohnen R., Möller H. J., Hegerl U. Treatment of depression with atypical features: A meta-analytic approach. Psychiatry Research 2006; 141(1)89–101, [INFOTRIEVE], [CROSSREF], [CSA]
- Mechcatie E. Patch approval: “Big moment” in psychopharm: Resistant depression patients may benefit. Clinical Psychiatry News 2006; 34(4)1–8, [CSA]
- Patka A. A., Pae C., Masand P. Transdermal selegiline: The new generation of monoamine oxidase inhibitors. CNS Spectrums 2006; 11(5)363–375, [CSA]
- Robinson D. S. Monoamine oxidase inhibitors: A new generation. Psychopharmacology Bulletin 2002; 36(3)124–138, [INFOTRIEVE], [CSA]
- Somerset Pharmaceuticals and Bristol-Myers Squibb. Emsam product information and medication guide. February, 2006, (EM-B0001-02-06)
- Stahl S. Essential psychopharmacology of depression and bipolar disorder. Cambridge University Press, New York 2000
- Stahl S. Essential psychopharmacology: The prescriber's guide, Rev. ed. Cambridge University Press, New York 2006
- Thase M. E. Therapeutic alternatives for difficult-to-treat depression: A narrative review of the state of the evidence. CNS Spectrums 2004; 9(11)808–821, [INFOTRIEVE], [CSA]